Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hims & Hers Health (HIMS – Research Report) and Celcuity (CELC – Research Report). Don't Miss our Black ...

On Friday, Hims & Hers Health Inc (HIMS) stock saw a decline, ending the day at $19.32 which represents a decrease of $-1.53 or -7.34% from the prior close of $20.85. The stock opened at $21.34 and ...

Shares of Hims & Hers Health jumped after the company added former Food and Drug Administration official Deb Autor to its board. The stock was up 8.8% at $21.02 in Monday trading. Shares have doubled ...

Hims & Hers Health, announced Deb Autor, former deputy commissioner at the FDA, will join the company’s board of directors, and Janet ...

Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS), the leading health and wellness platform, today announced Deb Autor, ...

Should you invest $1,000 in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The ...

Hims & Hers (NYSE: HIMS) is disrupting the healthcare market with its innovative patient treatment approach. Read More: Earn ...

Hims & Hers offers personalized telehealth services, with a stock price that reflects high-growth potential. See why we ...

Podcaster Joe Rogan has weighed in on actress and pop star Jennifer Lopez getting divorced from her husband Ben Affleck earlier this year. Lopez's split ...

Popular golf influencer Paige Spiranac has returned with another one of her weekly "Beginner's Guide to Golf" tutorial videos. This week she addresses ...

Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon One ...

Hims & Hers Health's stock dropped 25% due to Amazon’s competition. Learn why HIM stock's 38% upside and strong growth make ...